The CEO of Walgreens Boots has stepped down after less than three years at the helm of the drug store chain that is undergoing a sizeable transformation, one that has come at a cost.

Walgreens Boots Alliance confirmed Rosalind Brewer's exit Friday. According to the Illinois company, the board of directors and Brewer “mutually agreed” to her resignation effective Thursday.

Ginger Graham, who currently serves as Walgreen Boots Alliance's lead independent director, has been named interim CEO.

“I am grateful to have had the opportunity to lead Walgreens Boots Alliance and to work alongside such talented and dedicated colleagues," Brewer said in a written statement. "I am confident that WBA is on track to be a leading consumer-centric healthcare company, serving thousands of communities across the country.”

Walgreens Boots Alliance, Inc. is the parent company of Walgreens and other consumer brands around the world — including Boots, Duane Reade, No7 Beauty Company, Benavides and Ahumada.

The company over the past several years has shifted its focus from providing medicines to get people through illnesses, to helping its customers avoid them.

That has included a major series of acquisitions aimed to put the company at the forefront of preventative care.

Walgreens acquired VillageMD for nearly $9-billion in November, an urgent and primary care chain. Two months earlier, it spent nearly $1.4 billion to buy the remaining stake in Shields Health Solutions it doesn’t already own and continue pushing into the fast-growing area of specialty pharmacy.

Company shares have been under heavy pressure as Walgreens attempts to transform itself. The stock has tumbled nearly 54% since the start of 2022.

Brewer has more experience in the retail side of the business, which “is simply not an area that Walgreens wants to pursue as a major growth opportunity,” said Neil Saunders, managing director of GlobalData.

“Healthcare is a lucrative sector and Walgreens is not wrong to see it as a major part of its future playbook," Saunders said. "However, the new permanent CEO will need to remember that it is possible to invest in both healthcare and retail. It should not be an either/or decision.”

Newly appointed acting CEO Ginger Graham, Saunders noted, has a much deeper background in the healthcare and pharma industries.

Shares for Walgreens Boots Alliance slipped about 1% at the opening bell Friday.

Share:
More In Business
UBS Completes Takeover of Credit Suisse in Deal to Stem Financial Turmoil
UBS said Monday that it has completed its takeover of embattled rival Credit Suisse, nearly three months after the Swiss government hastily arranged a rescue deal to combine the country's two largest banks in a bid to safeguard Switzerland’s reputation as a global financial center and choke off market turmoil.
Lawmakers Propose Weakening Rule for Airfare Price Transparency
“Any consumer can tell you that online airline bookings are confusing enough," said William McGee, an aviation expert at the American Economic Liberties Project. "The last thing we need is to roll back an existing protection that provides effective transparency.”
Next Week on the Street: Trump in Court, Fed Meeting and More Earnings
Cheddar News checks in to see what to look out for Next Week on the Street as former president Donald Trump makes an appearance in federal court after being indicted. Investors will also keep an eye on the Federal Reserve meeting to see what comes out of that while earnings continue to pour in.
Load More